Assessment of health-related quality of life and treatment satisfaction and their associated factors among older adults with heart failure: a prospective observational study in selected hospitals in Northwest Ethiopia

BMJ Open. 2026 Feb 12;16(2):e103989. doi: 10.1136/bmjopen-2025-103989.ABSTRACTOBJECTIVES: To assess health-related quality of life (HRQoL), treatment satisfaction and associated factors among older adults with acute heart failure in Northwest Ethiopia.DESIGN: Prospective, multicentre observational s

G Getachew Yitayew Tarekegn

Human umbilical mesenchymal stem cell-derived mitochondria transplantation suppresses sFLT-1 secretion by regulating calcineurin-NFAT-dependent pathways in angiotensin II-induced preeclampsia rats

Stem Cell Res Ther. 2026 Feb 13. doi: 10.1186/s13287-026-04930-9. Online ahead of print.ABSTRACTBACKGROUND: Mitochondrial transplantation (Mito-T) is a novel therapeutic strategy for ischaemic cardiovascular diseases. This study aimed to test the efficacy of human umbilical mesenchymal stem cell-der

H Hui Xing Cui

Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trial

Trials. 2026 Feb 14. doi: 10.1186/s13063-026-09508-7. Online ahead of print.ABSTRACTBACKGROUND: Antihypertensive treatment is effective at reducing the risk of cardiovascular disease, but is associated with adverse events, particularly in older patients with frailty. As a result, deprescribing antih

M Melanie Carr